Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shereen Ezzat

Showing results (51-60 of 249) with videos related to

Pageof 25
Sort By:
Molecular Endocrinology (Baltimore, Md.)|July 3, 2004
Pituitary tumor-derived fibroblast growth factor receptor 4 isoform disrupts neural cell-adhesion molecule/N-cadherin signaling to diminish cell adhesiveness: a mechanism underlying pituitary neoplasiaShereen Ezzat, Lei Zheng, Sylvia L Asa
Molecular and Cellular Endocrinology|July 17, 2017
Epigenetics of pituitary tumors: Pathogenetic and therapeutic implicationsShereen Ezzat, Sonia Cheng, Sylvia L Asa
The American Journal of Pathology|March 30, 2010
Genetic and epigenetic mechanisms down-regulate FGF receptor 2 to induce melanoma-associated antigen A in breast cancerXuegong Zhu, Sylvia L Asa, Shereen Ezzat
Cancer Research|May 17, 2008
Ikaros modulates cholesterol uptake: a link between tumor suppression and differentiationSiobhan Loeper, Sylvia L Asa, Shereen Ezzat
Neuro-Oncology Advances|July 28, 2025
Clinical integration and application of the 2022 WHO pituitary tumor classificationSylvia L Asa, Shereen Ezzat, Ozgur Mete
Journal of Clinical Medicine|September 16, 2018
The Diagnosis and Clinical Significance of Paragangliomas in Unusual LocationsSylvia L Asa, Shereen Ezzat, Ozgur Mete
The American Journal of Pathology|August 26, 2003
Ikaros isoforms in human pituitary tumors: distinct localization, histone acetylation, and activation of the 5' fibroblast growth factor receptor-4 promoterShereen Ezzat, Shunjiang Yu, Sylvia L Asa
Molecular and Cellular Endocrinology|September 19, 2017
The retrotransposon gag domain containing protein Rgag4 is an Ikaros target in the pituitaryZhongyi Shen, Sylvia L Asa, Shereen Ezzat
Molecular and Cellular Endocrinology|November 6, 2016
Ikaros and its interacting partner CtBP target the metalloprotease ADAMTS10 to modulate pituitary cell functionZhongyi Shen, Sylvia L Asa, Shereen Ezzat
Endocrinology and Metabolism Clinics of North America|May 27, 2008
Epigenetic dysregulation in thyroid neoplasiaTetsuo Kondo, Sylvia L Asa, Shereen Ezzat
Pageof 25

Showing results (51-60 of 249) with videos related to

Sort By:
Pageof 25
Molecular Endocrinology (Baltimore, Md.)|July 3, 2004
Pituitary tumor-derived fibroblast growth factor receptor 4 isoform disrupts neural cell-adhesion molecule/N-cadherin signaling to diminish cell adhesiveness: a mechanism underlying pituitary neoplasiaShereen Ezzat, Lei Zheng, Sylvia L Asa
Molecular and Cellular Endocrinology|July 17, 2017
Epigenetics of pituitary tumors: Pathogenetic and therapeutic implicationsShereen Ezzat, Sonia Cheng, Sylvia L Asa
The American Journal of Pathology|March 30, 2010
Genetic and epigenetic mechanisms down-regulate FGF receptor 2 to induce melanoma-associated antigen A in breast cancerXuegong Zhu, Sylvia L Asa, Shereen Ezzat
Cancer Research|May 17, 2008
Ikaros modulates cholesterol uptake: a link between tumor suppression and differentiationSiobhan Loeper, Sylvia L Asa, Shereen Ezzat
Neuro-Oncology Advances|July 28, 2025
Clinical integration and application of the 2022 WHO pituitary tumor classificationSylvia L Asa, Shereen Ezzat, Ozgur Mete
Journal of Clinical Medicine|September 16, 2018
The Diagnosis and Clinical Significance of Paragangliomas in Unusual LocationsSylvia L Asa, Shereen Ezzat, Ozgur Mete
The American Journal of Pathology|August 26, 2003
Ikaros isoforms in human pituitary tumors: distinct localization, histone acetylation, and activation of the 5' fibroblast growth factor receptor-4 promoterShereen Ezzat, Shunjiang Yu, Sylvia L Asa
Molecular and Cellular Endocrinology|September 19, 2017
The retrotransposon gag domain containing protein Rgag4 is an Ikaros target in the pituitaryZhongyi Shen, Sylvia L Asa, Shereen Ezzat
Molecular and Cellular Endocrinology|November 6, 2016
Ikaros and its interacting partner CtBP target the metalloprotease ADAMTS10 to modulate pituitary cell functionZhongyi Shen, Sylvia L Asa, Shereen Ezzat
Endocrinology and Metabolism Clinics of North America|May 27, 2008
Epigenetic dysregulation in thyroid neoplasiaTetsuo Kondo, Sylvia L Asa, Shereen Ezzat
Pageof 25